Effects of Replacing a Central Glycine Residue in GLP-1 on Receptor Affinity and Signaling Profile

Chembiochem. 2023 Nov 2;24(21):e202300504. doi: 10.1002/cbic.202300504. Epub 2023 Sep 13.

Abstract

Agonists of the glucagon-like peptide-1 receptor (GLP-1R) are used to treat diabetes and obesity. Cryo-EM structures indicate that GLP-1 is completely α-helical when bound to the GLP-1R. The mature form of this hormone, GLP-1(7-36), contains a glycine residue near the center (Gly22). Since glycine has the second-lowest α-helix propensity among the proteinogenic α-amino acid residues, and Gly22 does not appear to make direct contact with the receptor, we were motivated to explore the impact on agonist activity of altering the α-helix propensity at this position. We examined GLP-1 analogues in which Gly22 was replaced with L-Ala, D-Ala, or β-amino acid residues with varying helix propensities. The results suggest that the receptor is reasonably tolerant of variations in helix propensity, and that the functional receptor-agonist complex may comprise a conformational spectrum rather than a single fixed structure.

Keywords: G protein-coupled receptors; GLP-1; backbone modification; helix propensity; α/β-peptide.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Amino Acid Sequence
  • Amino Acids / chemistry
  • Glucagon-Like Peptide 1*
  • Glucagon-Like Peptide-1 Receptor / agonists
  • Glycine* / chemistry
  • Protein Conformation, alpha-Helical

Substances

  • Glucagon-Like Peptide 1
  • Glycine
  • Amino Acids
  • Glucagon-Like Peptide-1 Receptor